(62)Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II) (Proportional Technologies)

N/A

Report date: 2025/12/01 17:16:38
NME

Base Information

Drug Name(62)Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II) (Proportional Technologies)
Drug Alias Name62Cu-ETS
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsRenal InsufficiencyRenal Artery Obstruction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProportional Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJeffrey L. Lacy
Active IndicationsN/A
Inactive IndicationsRenal InsufficiencyRenal Artery Obstruction

Other Information

ATC CodeN/A
Related LinksN/A